Use of Intravenous Liposoluble Contrast Material for the Examination of the Liver and Spleen in Lymphoma
- 1 October 1981
- journal article
- research article
- Published by Wolters Kluwer Health in Journal of Computer Assisted Tomography
- Vol. 5 (5) , 709-713
- https://doi.org/10.1097/00004728-198110000-00021
Abstract
An experimental contrast material was developed that, after i.v. injection, selectively opacifies the spleen and liver on computed tomography (CT). The contrast material contains iodinated ester of poppy seed oil in an emulsified form. Clinical trials were recently initiated to test the value of this contrast agent in Hodgkin''s and non Hodgkin''s lymphomas. Two initial patients in whom lesions were found in the spleen or liver following the infusion of the experimental contrast material that were not visualized on the precontrast and urographic contrast material enhanced CT scans are presented.This publication has 8 references indexed in Scilit:
- Computed tomography in hepatic lymphoma.Radiology, 1981
- Clinical trials with a new intravenous liposoluble contrast material for computed tomography of the liver and spleen.Radiology, 1980
- Use of Liposoluble Contrast Material to Separate Left Renal and Splenic Parenchyma on Computed TomographyJournal of Computer Assisted Tomography, 1980
- Development and Experimental Evaluation of a Contrast Medium for Computed Tomographic Examination of the Liver and SpleenJournal of Computer Assisted Tomography, 1979
- Formulation and Evaluation of Ethiodized Oil Emulsion for Intravenous HepatographyJournal of Pharmaceutical Sciences, 1979
- Computed tomographic scanning in patients with lymphomaCancer, 1978
- Contributions of Computed Tomography in the Staging and Management of Malignant LymphomaRadiology, 1977
- Computed Tomography as an Adjunct in the Staging of Hodgkin's Disease and Non-Hodgkin's LymphomasRadiology, 1977